224 related articles for article (PubMed ID: 11907228)
1. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.
Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN
J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228
[TBL] [Abstract][Full Text] [Related]
2. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties.
Chaubey B; Tripathi S; Ganguly S; Harris D; Casale RA; Pandey VN
Virology; 2005 Jan; 331(2):418-28. PubMed ID: 15629784
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
Kaushik N; Basu A; Pandey VN
Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.
Ganguly S; Chaubey B; Tripathi S; Upadhyay A; Neti PV; Howell RW; Pandey VN
Oligonucleotides; 2008 Sep; 18(3):277-86. PubMed ID: 18729823
[TBL] [Abstract][Full Text] [Related]
7. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.
Das I; Désiré J; Manvar D; Baussanne I; Pandey VN; Décout JL
J Med Chem; 2012 Jul; 55(13):6021-32. PubMed ID: 22698070
[TBL] [Abstract][Full Text] [Related]
8. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
[TBL] [Abstract][Full Text] [Related]
10. Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome.
Upadhyay A; Ponzio NM; Pandey VN
Oligonucleotides; 2008 Dec; 18(4):329-35. PubMed ID: 19006449
[TBL] [Abstract][Full Text] [Related]
11. An efficient biodelivery system for antisense polyamide nucleic acid (PNA).
Mehiri M; Upert G; Tripathi S; Di Giorgio A; Condom R; Pandey VN; Patino N
Oligonucleotides; 2008 Sep; 18(3):245-56. PubMed ID: 18707540
[TBL] [Abstract][Full Text] [Related]
12. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
15. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a new class of HIV-1 inhibitors.
Farese-Di Giorgio A; Pairot S; Patino N; Condom R; Di Giorgio C; Aumelas A; Aubertin AM; Guedj R
Nucleosides Nucleotides; 1999 Feb; 18(2):263-75. PubMed ID: 10067276
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
18. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
Lisziewicz J; Rappaport J; Dhar R
New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
[TBL] [Abstract][Full Text] [Related]
19. Single acute-dose and repeat-doses toxicity of anti-HIV-1 PNA TAR-penetratin conjugate after intraperitoneal administration to mice.
Chaubey B; Tripathi S; Pandey VN
Oligonucleotides; 2008; 18(1):9-20. PubMed ID: 18321159
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
